205 related articles for article (PubMed ID: 15031260)
1. Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.
West J; Fagan K; Steudel W; Fouty B; Lane K; Harral J; Hoedt-Miller M; Tada Y; Ozimek J; Tuder R; Rodman DM
Circ Res; 2004 Apr; 94(8):1109-14. PubMed ID: 15031260
[TBL] [Abstract][Full Text] [Related]
2. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
6. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
7. The mouse through the looking glass: a new door into the pathophysiology of pulmonary hypertension.
Rabinovitch M
Circ Res; 2004 Apr; 94(8):1001-4. PubMed ID: 15117827
[No Abstract] [Full Text] [Related]
8. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary arterial hypertension and BMP system abnormality].
Otsuka F
Nihon Rinsho; 2008 Nov; 66(11):2083-90. PubMed ID: 19051724
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein receptor-2 and pulmonary arterial hypertension: unraveling a riddle inside an enigma?
Stewart DJ
Circ Res; 2005 May; 96(10):1033-5. PubMed ID: 15920025
[No Abstract] [Full Text] [Related]
11. BMP signaling controls PASMC KV channel expression in vitro and in vivo.
Young KA; Ivester C; West J; Carr M; Rodman DM
Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L841-8. PubMed ID: 16339782
[TBL] [Abstract][Full Text] [Related]
12. Generation of a floxed allele of the mouse BMP type II receptor gene.
Beppu H; Lei H; Bloch KD; Li E
Genesis; 2005 Mar; 41(3):133-7. PubMed ID: 15736264
[TBL] [Abstract][Full Text] [Related]
13. BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells.
Lagna G; Nguyen PH; Ni W; Hata A
Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L1059-67. PubMed ID: 17030903
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells.
Yu PB; Deng DY; Beppu H; Hong CC; Lai C; Hoyng SA; Kawai N; Bloch KD
J Biol Chem; 2008 Feb; 283(7):3877-88. PubMed ID: 18042551
[TBL] [Abstract][Full Text] [Related]
17. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
18. Identification and analysis of type II TGF-β receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells.
Wu N; Zhao Y; Yin Y; Zhang Y; Luo J
Acta Biochim Biophys Sin (Shanghai); 2010 Oct; 42(10):699-708. PubMed ID: 20801928
[TBL] [Abstract][Full Text] [Related]
19. Signaling molecules in nonfamilial pulmonary hypertension.
Du L; Sullivan CC; Chu D; Cho AJ; Kido M; Wolf PL; Yuan JX; Deutsch R; Jamieson SW; Thistlethwaite PA
N Engl J Med; 2003 Feb; 348(6):500-9. PubMed ID: 12571257
[TBL] [Abstract][Full Text] [Related]
20. Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension.
Rabinovitch M
J Clin Invest; 2001 Oct; 108(8):1109-11. PubMed ID: 11602617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
